Voloridge Investment Management LLC Reduces Stake in AdaptHealth Corp. (NASDAQ:AHCO)

Voloridge Investment Management LLC cut its stake in shares of AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 36.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 236,701 shares of the company's stock after selling 135,573 shares during the quarter. Voloridge Investment Management LLC owned approximately 0.18% of AdaptHealth worth $2,253,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Segall Bryant & Hamill LLC lifted its stake in shares of AdaptHealth by 29.8% in the fourth quarter. Segall Bryant & Hamill LLC now owns 4,803,981 shares of the company's stock valued at $45,734,000 after buying an additional 1,102,173 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in shares of AdaptHealth by 17.6% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,379,715 shares of the company's stock valued at $32,174,000 after buying an additional 505,180 shares in the last quarter. Geode Capital Management LLC lifted its stake in shares of AdaptHealth by 0.7% in the fourth quarter. Geode Capital Management LLC now owns 2,467,769 shares of the company's stock valued at $23,499,000 after buying an additional 16,596 shares in the last quarter. Kennedy Capital Management LLC lifted its stake in shares of AdaptHealth by 6.0% in the fourth quarter. Kennedy Capital Management LLC now owns 1,767,310 shares of the company's stock valued at $16,825,000 after buying an additional 99,326 shares in the last quarter. Finally, Principal Financial Group Inc. lifted its stake in shares of AdaptHealth by 204.0% in the fourth quarter. Principal Financial Group Inc. now owns 1,652,765 shares of the company's stock valued at $15,735,000 after buying an additional 1,109,021 shares in the last quarter. 82.67% of the stock is owned by institutional investors.

AdaptHealth Stock Performance

NASDAQ:AHCO traded up $0.08 during trading hours on Friday, reaching $9.06. The stock had a trading volume of 1,273,745 shares, compared to its average volume of 1,286,034. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24. The stock has a 50 day simple moving average of $8.99 and a 200 day simple moving average of $9.61. AdaptHealth Corp. has a 12-month low of $7.11 and a 12-month high of $11.90. The stock has a market cap of $1.22 billion, a P/E ratio of -5.49, a price-to-earnings-growth ratio of 1.08 and a beta of 1.64.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the stock. Truist Financial dropped their price objective on shares of AdaptHealth from $14.00 to $13.00 and set a "buy" rating on the stock in a research note on Monday, May 12th. UBS Group dropped their price target on shares of AdaptHealth from $12.00 to $11.00 and set a "buy" rating on the stock in a research report on Thursday, February 13th. Royal Bank of Canada reduced their price objective on shares of AdaptHealth from $14.00 to $13.00 and set an "outperform" rating for the company in a research report on Thursday, May 8th. Canaccord Genuity Group lifted their target price on shares of AdaptHealth from $13.00 to $14.00 and gave the stock a "buy" rating in a research report on Wednesday, February 26th. Finally, Robert W. Baird boosted their target price on AdaptHealth from $14.00 to $16.00 and gave the stock an "outperform" rating in a research note on Thursday, February 27th. Five analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus price target of $13.40.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.